NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Cyber Resilience and Recovery Amid Evolving Cyber Threats
Data durability is a key aspect of NIST’s cybersecurity framework for public and private organizations.
21m listen -
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen -
The CAIOs Leading Responsible AI Development Across Government
Since the White House's AI executive order, federal agencies are in the process of naming chief artificial intelligence officers.
7m read -
Defense Board to Pitch Solutions for Closing Tech Talent Gaps
Defense Innovation Board members cite need to modernize people management the same way government modernizes technology.
4m read